Barry Moze - Nov 4, 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Chief Admin. Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Nov 4, 2021
Transactions value $
-$7,385,652
Form type
4
Date filed
11/5/2021, 05:00 PM
Previous filing
Jul 30, 2021
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $66.4K +3K +3.96% $22.14* 78.7K Nov 4, 2021 Direct
transaction HZNP Ordinary Shares Options Exercise $5.23K +443 +0.56% $11.81* 79.1K Nov 4, 2021 Direct
transaction HZNP Ordinary Shares Options Exercise $1.05M +72.3K +91.38% $14.48* 151K Nov 4, 2021 Direct
transaction HZNP Ordinary Shares Sale -$2.58M -23.4K -15.44% $110.17 128K Nov 4, 2021 Direct F1, F2
transaction HZNP Ordinary Shares Sale -$1.77M -15.9K -12.38% $111.75 112K Nov 4, 2021 Direct F1, F3
transaction HZNP Ordinary Shares Sale -$693K -6.15K -5.48% $112.60 106K Nov 4, 2021 Direct F1, F4
transaction HZNP Ordinary Shares Sale -$2.03M -17.9K -16.85% $113.56 88.2K Nov 4, 2021 Direct F1, F5
transaction HZNP Ordinary Shares Sale -$774K -6.76K -7.67% $114.43 81.4K Nov 4, 2021 Direct F1, F6
transaction HZNP Ordinary Shares Sale -$661K -5.72K -7.03% $115.45 75.7K Nov 4, 2021 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -3K -1.82% $0.00 162K Nov 4, 2021 Ordinary Shares 3K $22.14 Direct F8
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -443 -100% $0.00* 0 Nov 4, 2021 Ordinary Shares 443 $11.81 Direct F8
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -72.3K -100% $0.00* 0 Nov 4, 2021 Ordinary Shares 72.3K $14.48 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.985 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.10 to $112.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.12 to $113.085 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.14 to $114.135 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.14 to $115.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.15 to $115.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The stock option is fully vested and exercisable.